Bio-IT World September 23, 2021
Allison Proffitt

Namita Limaye, Research VP at IDC, gave a broad overview of IDC’s survey findings over the past 18 months at this week’s Bio-IT World Conference and Expo held in Boston and online. She highlighted trends in the life sciences that included increased collaboration, speedier adoption of technologies, and a look at how executives are viewing—and planning—digital transformation.

After the unprecedented disruption of the COVID-19 pandemic, companies in the life sciences industry returned with a focus on digital resiliency—seeking to recover and grow in the new times.

In speaking with life sciences executives, IDC identified a few shifts in C-suite thinking during the pandemic. Executives focused on the short term, ensuring business continuity and digital resiliency and prioritizing patient and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Health IT, Pharma / Biotech, Public Health / COVID, Technology
Boehringer signs $1.3B deal with RNA biotech Ochre Bio to team up against MASH
Bristol Myers taps startup to boost cell therapy production
With $380M deal, Bristol Myers Squibb ups the ante with cell therapy manufacturer Cellares
Boehringer Ingelheim Strikes Regenerative Med R&D Deal Spanning MASH & More Liver Diseases
Metsera Launches with $290M to Develop Next Generation Weight Loss Products

Share This Article